ANNA ELKINS: Open Payments
NPI 1588095954 · FLATWOODS, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,078 in 64 payments from 14 companies in 2025. Trend: 2023 $757 · 2024 $856 · 2025 $1,078
Food & beverage: $1,078
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 17 | $262 |
| ABBVIE INC. | 16 | $233 |
| Novo Nordisk Inc | 8 | $159 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $68 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| Lilly USA, LLC | 4 | $61 |
| Corcept Therapeutics | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Abbott Laboratories | 2 | $31 |
Products named: NURTEC ODT, QULIPTA, VRAYLAR, ELIQUIS, Ozempic, XIFAXAN, TRELEGY ELLIPTA, MOUNJARO.
Industry payments across KY — which companies pay providers there.
